CASP9 and non-small cell lung carcinoma: For example, some studies demonstrate that PINK1 depletion in the non-small cell lung cancer (NSCLC) A549 cell line via shRNA reduced cancer cell proliferation, increased cell death, decreased ATP production, inhibited mitophagy, and increased ROS levels and caspase-9-dependent apoptosis [67].